Patients with cardiometabolic conditions consistently had higher costs than those without. For example, costs were 14% to 21% ...
A new meta-analysis of prospective studies finds artificial intelligence performs similarly to dermatologists in melanoma ...
The specific timing of a teenager’s sleep-wake cycle may be one of the strongest behavioral factors influencing adolescents’ ...
A program that charges no copayments for virtual visits and takes virtual-first approach has enrolled more than 150,000 members and yielded savings of $46 8 per member per year, Blue Shield of ...
Yuvezzi is available at retail pharmacies or directly to patients through PHIL, an all-in-one digital hub and ...
One year after FDA approval, Journavx (suzetrigine) offers a promising non-opioid option for acute pain, but experts have concerns about long-term safety, opioid-sparing effects and real-world use.
Food does not affect Foundayo, so it can be taken with or without food. In contrast, oral Wegovy has to be taken on an empty ...
She recently attended the 2026 American Academy of Dermatology Annual Meeting in Denver, where she spoke at several sessions, ...
Northwell Health’s flagship hospital, Lenox Hill Hospital, plans to build a $6.9 million outpatient mental health clinic on ...
Specifically, Black women had a 41% higher relative risk of coronary heart disease and a 16% rate of premature menopause, ...
Opioids such as morphine, oxycodone and fentanyl provide pain relief by binding to mu-opioid receptors, which are specialized ...
The FDA has approved Eli Lilly's oral GLP-1, Foundayo. Let the heated rivalry with oral Wegovy begin
Eli Lilly announced this morning that the FDA has, as was expected, approved its oral GLP-1, orforglipron, as treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results